Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - July 2001

  1. Boulianne, N., De Serres, G., Duval, B., Shadmani, R., and Rochette, L. Clinical manifestations and incidence of oculo-respiratory syndrome following influenza vaccination--Quebec, 2000 Can.Commun.Dis.Rep. 5-15-2001, 27 (10): 85-90.
  2. Brayden, R. and France, E. K. Efficient vaccination practices Pediatr.Ann. 2001, 30 (5): 284-288.
  3. Buxton, J. A., Skowronski, D. M., Ng, H., Marion, S. A., Li, Y., King, A., and Hockin, J. Influenza revaccination of elderly travelers: antibody response to single influenza vaccination and revaccination at 12 weeks J.Infect.Dis. 7-15-2001, 184 (2): 188-191.
  1. Dagan, R., Amir, J., Ashkenazi, S., Hardt, K., and Kaufhold, A. Early responses to nonconjugated polyribosylribitol phosphate challenge as evidence of immune memory after combined diphtheria-tetanus-pertussis-polio-Haemophilus influenzae type b primary vaccination Pediatr.Infect.Dis.J. 2001, 20 (6): 587-592.
  2. DeStefano, F. More evidence to reassure physicians and parents about vaccination West J.Med. 2001, 174 (6): 390-391.
  3. Earhart, K. C., Beadle, C., Miller, L. K., Pruss, M. W., Gray, G. C., Ledbetter, E. K., and Wallace, M. R. Outbreak of influenza in highly vaccinated crew of u.s. navy ship Emerg.Infect.Dis. 2001, 7 (3): 463-465.
  1. Fiechtner, H. B. and Falls, S. Vaccination myths and misconceptions S D.J.Med. 2001, 54 (5): 165-166.
  2. Griffin, J. P. MMR vaccination: how reassuring is reassurance? Adverse Drug React.Toxicol.Rev. 2001, 20 (1): 1-2.
  3. Hamilton, M. The MMR vaccination and autism: a lay person's contribution West Indian Med.J. 2001, 50 (1): 87-89.
  4. Hernandez-Suarez, C. M. A note on the distribution of the number of vaccinated infected under non-random mixing conditions Stat.Med. 7-15-2001, 20 (13): 1983-1986.
  5. Heyderman, R. Commentary: Should programmes for community-level meningococcal vaccination be considered in Australia-an economic evaluation Int.J.Epidemiol. 2001, 30 (3): 578-579.
  6. Houcke-Bruge, C., Delaporte, E., Catteau, B., Martin, De Lassalle, and Piette, F. [Granuloma annulare following BCG vaccination] Ann.Dermatol.Venereol. 2001, 128 (4): 541-544.
  7. Humiston, S. G. and Strikas, R. A. Routine childhood vaccination update: educating the office staff Pediatr.Ann. 2001, 30 (6): 329-341.
  8. Iwane, M. K. and Schwartz, B. Pediatric influenza immunization: should healthy children be vaccinated? Pediatr.Ann. 2001, 30 (6): 354-357.
  9. Kaji, M., Tsuru, T., and Oizumi, K. [Efficacy and safety of influenza vaccination to elderly patients with neurological diseases] Kansenshogaku Zasshi. 2001, 75 (5): 411-415. infection
  10. Vaccine. 7-16-2001, 19 (28-29): 4011-4019.
  11. Law, B. J. Chickenpox vaccination, not chickenpox, should be routine for Canadian children CMAJ. 5-15-2001, 164 (10): 1454-1455.
  12. De Los Rios, Martin R., Garcia, Marin N., Sanz, Moreno J., and Ballester, Orcal E. [Mumps in an urban area of the Community of Madrid. Vaccination status, diagnosis and intervention measures] Aten.Primaria. 6-15-2001, 28 (1): 10-16.
  13. Miller, P. L., Frawley, S. J., and Sayward, F. G. Exploring the utility of demographic data and vaccination history data in the deduplication of immunization registry patient records J.Biomed.Inform. 2001, 34 (1): 37-50.
  14. Mollenkopf, H., Dietrich, G., and Kaufmann, S. H. Intracellular bacteria as targets and carriers for vaccination Biol.Chem. 2001, 382 (4): 521-532.
  15. Oh, J. KePRO priming for adult vaccination campaign Pa Med. 1999, 102 (11): 6.
  16. Russell, M. L. Influenza vaccination in Alberta long-term care facilities CMAJ. 5-15-2001, 164 (10): 1423-1427.
  17. Schellenberg, D., Menendez, C., Kahigwa, E., Aponte, J., Vidal, J., Tanner, M., Mshinda, H., and Alonso, P. Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial Lancet. 5-12-2001, 357 (9267): 1471-1477.
  18. Skull, S., Butler, J., Robinson, P., and Carnie, J. Should programmes for community-level meningococcal vaccination be considered in Australia? An economic evaluation Int.J.Epidemiol. 2001, 30 (3): 571-578.
  19. Watanabe, T. and Onda, H. Henoch-Schonlein purpura with antiphospholipid antibodies following an influenza vaccination Pediatr.Nephrol. 2001, 16 (5): 458-459. Yamazaki, T., Suzuki, T., and Yamamoto, K. Vaccinating Japanese schoolchildren against influenza N.Engl.J.Med. 6-21-2001, 344 (25): 1947-1948.

Back to Top